Talima Therapeutics

About:

Talima Therapeutics is a drug delivery company developing customized systems that optimize the local therapeutic performance.

Website: http://www.talima.com

Top Investors: U.S. Venture Partners, DeNovo Ventures, Palo Alto Investors, Latterell Venture Partners

Description:

Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.

Total Funding Amount:

$20.6M

Headquarters Location:

San Carlos, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)talima.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-05-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai